Polypharmacy and potential drug–drug interactions among Greenland’s care home residents

BACKGROUND: As lifetime expectancy in Greenland is steadily increasing, so is the proportion of elderly Greenlanders. Old age is associated with polypharmacy, and in this study, we aim to describe the prevalence and characteristics of polypharmacy among the care home residents in Greenland. METHODS:...

Full description

Bibliographic Details
Published in:Therapeutic Advances in Drug Safety
Main Authors: Albertsen, Nadja, Sommer, Tine Gjedde, Olsen, Thomas Mikkel, Prischl, Anna, Kallerup, Hans, Andersen, Stig
Format: Text
Language:English
Published: SAGE Publications 2022
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243492/
https://doi.org/10.1177/20420986221103918
id ftpubmed:oai:pubmedcentral.nih.gov:9243492
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9243492 2023-05-15T16:25:58+02:00 Polypharmacy and potential drug–drug interactions among Greenland’s care home residents Albertsen, Nadja Sommer, Tine Gjedde Olsen, Thomas Mikkel Prischl, Anna Kallerup, Hans Andersen, Stig 2022-06-26 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243492/ https://doi.org/10.1177/20420986221103918 en eng SAGE Publications http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243492/ http://dx.doi.org/10.1177/20420986221103918 © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). CC-BY-NC Ther Adv Drug Saf Original Research Text 2022 ftpubmed https://doi.org/10.1177/20420986221103918 2022-07-03T01:07:18Z BACKGROUND: As lifetime expectancy in Greenland is steadily increasing, so is the proportion of elderly Greenlanders. Old age is associated with polypharmacy, and in this study, we aim to describe the prevalence and characteristics of polypharmacy among the care home residents in Greenland. METHODS: Eight care homes in Greenland were visited between 2010 and 2016. Questionnaires including information on prescribed medication and comorbidities were collected and analyzed. Drugs were categorized according to Anatomical Therapeutic Chemical (ATC) category, and potential drug–drug interactions (pDDIs) were assessed using the Danish Interaction Database. Polypharmacy was defined as five or more prescribed drugs. RESULTS: All 244 eligible residents were included in the study. The median number of prescribed drugs per resident was six, and women were prescribed more drugs than men (median six versus five). More than 60% of all residents fulfilled the criteria for polypharmacy. The residents in the polypharmacy group had a higher body mass index (26.9 versus 24.3) and more chronic diseases (median two versus one), and more often pulmonary (14% versus 1%) or endocrine disease (22% versus 2%) than in the non-polypharmacy group. The most prescribed drugs belonged to ATC category N (nervous system, 78% of the residents). Finally, pDDIs were found among 61% of the residents and were more common in the capital (77%), which also had the highest proportion of residents with polypharmacy (77%). CONCLUSION: This is the first study to describe the patterns of polypharmacy and pDDIs among the elderly in care homes in Greenland. Our findings indicate that polypharmacy is as common in Greenland as elsewhere in the Western world, but there are local differences in the prevalence. PLAIN LANGUAGE SUMMARY: Polypharmacy among the elderly in care homes in Greenland The lifetime expectancy of the Greenlandic population is increasing, and so is the number of elderly Greenlanders. Previous studies have shown that the elderly have a higher ... Text Greenland greenlander* greenlandic PubMed Central (PMC) Greenland Therapeutic Advances in Drug Safety 13 204209862211039
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Original Research
spellingShingle Original Research
Albertsen, Nadja
Sommer, Tine Gjedde
Olsen, Thomas Mikkel
Prischl, Anna
Kallerup, Hans
Andersen, Stig
Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
topic_facet Original Research
description BACKGROUND: As lifetime expectancy in Greenland is steadily increasing, so is the proportion of elderly Greenlanders. Old age is associated with polypharmacy, and in this study, we aim to describe the prevalence and characteristics of polypharmacy among the care home residents in Greenland. METHODS: Eight care homes in Greenland were visited between 2010 and 2016. Questionnaires including information on prescribed medication and comorbidities were collected and analyzed. Drugs were categorized according to Anatomical Therapeutic Chemical (ATC) category, and potential drug–drug interactions (pDDIs) were assessed using the Danish Interaction Database. Polypharmacy was defined as five or more prescribed drugs. RESULTS: All 244 eligible residents were included in the study. The median number of prescribed drugs per resident was six, and women were prescribed more drugs than men (median six versus five). More than 60% of all residents fulfilled the criteria for polypharmacy. The residents in the polypharmacy group had a higher body mass index (26.9 versus 24.3) and more chronic diseases (median two versus one), and more often pulmonary (14% versus 1%) or endocrine disease (22% versus 2%) than in the non-polypharmacy group. The most prescribed drugs belonged to ATC category N (nervous system, 78% of the residents). Finally, pDDIs were found among 61% of the residents and were more common in the capital (77%), which also had the highest proportion of residents with polypharmacy (77%). CONCLUSION: This is the first study to describe the patterns of polypharmacy and pDDIs among the elderly in care homes in Greenland. Our findings indicate that polypharmacy is as common in Greenland as elsewhere in the Western world, but there are local differences in the prevalence. PLAIN LANGUAGE SUMMARY: Polypharmacy among the elderly in care homes in Greenland The lifetime expectancy of the Greenlandic population is increasing, and so is the number of elderly Greenlanders. Previous studies have shown that the elderly have a higher ...
format Text
author Albertsen, Nadja
Sommer, Tine Gjedde
Olsen, Thomas Mikkel
Prischl, Anna
Kallerup, Hans
Andersen, Stig
author_facet Albertsen, Nadja
Sommer, Tine Gjedde
Olsen, Thomas Mikkel
Prischl, Anna
Kallerup, Hans
Andersen, Stig
author_sort Albertsen, Nadja
title Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
title_short Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
title_full Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
title_fullStr Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
title_full_unstemmed Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
title_sort polypharmacy and potential drug–drug interactions among greenland’s care home residents
publisher SAGE Publications
publishDate 2022
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243492/
https://doi.org/10.1177/20420986221103918
geographic Greenland
geographic_facet Greenland
genre Greenland
greenlander*
greenlandic
genre_facet Greenland
greenlander*
greenlandic
op_source Ther Adv Drug Saf
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243492/
http://dx.doi.org/10.1177/20420986221103918
op_rights © The Author(s), 2022
https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
op_rightsnorm CC-BY-NC
op_doi https://doi.org/10.1177/20420986221103918
container_title Therapeutic Advances in Drug Safety
container_volume 13
container_start_page 204209862211039
_version_ 1766014816494813184